Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 5
2007 3
2008 4
2009 2
2010 1
2011 4
2012 11
2013 5
2014 1
2015 5
2016 1
2017 5
2018 5
2019 3
2020 5
2021 1
2022 1
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Sanchez MB, Vasconcelos Cordoba B, Pavlovsky C, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, García de Labanca A, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Levy EM, Bianchini M. Sanchez MB, et al. Among authors: mordoh j. Front Immunol. 2023 Sep 25;14:1241600. doi: 10.3389/fimmu.2023.1241600. eCollection 2023. Front Immunol. 2023. PMID: 37818372 Free PMC article. Clinical Trial.
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Pavlovsky C, Vasconcelos Cordoba B, Sanchez MB, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, de Labanca AG, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Cueto G, Miranda S, Levy EM, Bianchini M. Pavlovsky C, et al. Among authors: mordoh j. J Hematol Oncol. 2023 Apr 29;16(1):43. doi: 10.1186/s13045-023-01440-6. J Hematol Oncol. 2023. PMID: 37120577 Free PMC article.
Lessons from cancer immunoediting in cutaneous melanoma.
Aris M, Barrio MM, Mordoh J. Aris M, et al. Among authors: mordoh j. Clin Dev Immunol. 2012;2012:192719. doi: 10.1155/2012/192719. Epub 2012 Aug 14. Clin Dev Immunol. 2012. PMID: 22924051 Free PMC article. Review.
Galectin-1 receptors in different cell types.
Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE. Elola MT, et al. Among authors: mordoh j. J Biomed Sci. 2005;12(1):13-29. doi: 10.1007/s11373-004-8169-5. J Biomed Sci. 2005. PMID: 15864736 Review.
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI, Aris M, Panouillot M, Porto M, Dieu-Nosjean MC, Teillaud JL, Barrio MM, Mordoh J. Bravo AI, et al. Among authors: mordoh j. Front Immunol. 2023 Aug 25;14:1231734. doi: 10.3389/fimmu.2023.1231734. eCollection 2023. Front Immunol. 2023. PMID: 37691949 Free PMC article.
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
Bordignon MB, Pesce Viglietti AI, Juliá EP, Sanchez MB, Rölle A, Mandó P, Sabatini L, Ostinelli A, Rizzo MM, Barrio MM, Mordoh J, Fainboim L, Levy EM. Bordignon MB, et al. Among authors: mordoh j. Cancer Immunol Immunother. 2023 Aug;72(8):2687-2700. doi: 10.1007/s00262-023-03448-w. Epub 2023 Apr 21. Cancer Immunol Immunother. 2023. PMID: 37081323
67 results